PanGen Biotech Inc. (KOSDAQ: A222110)
Health Care · Biotechnology · KR
₩4,845.00
+3.75% today · -21.1% 1Y
PanGen Biotech Inc. (KOSDAQ: A222110) operates in the Biotechnology industry within the Health Care sector. The company is valued at $49.11M.
Over the last twelve months the share price has lost 21.1%, trading between 4.22K and 8.51K.
Tweenvest scores PanGen Biotech Inc. across four factors: quality 61/100, value 50/100, growth 69/100. Its strongest factor is growth.
A222110 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.11M
- Revenue (TTM)
- $9.15M
- P/E
- 62.76
- EPS
- 77.19
- Dividend yield
- —
- Beta (5Y)
- -0.12
- 52-week high
- ₩8,510.00
- 52-week low
- ₩4,220.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.51M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Arecor Therapeutics plcAIM: AREC | $49.86M | £0.83 | +13.79% |
| Alterity Therapeutics LimitedASX: ATH | $49.42M | AU$0.31 | -12.68% |
| iBio, Inc.NasdaqCM: IBIO | $49.28M | $0.77 | -12.02% |
| Adicet Bio, Inc.NasdaqCM: ACET | $49.19M | $4.57 | -18.54% |
| Xspray Pharma AB (publ)OM: XSPRAY | $48.91M | Skr10.24 | -0.58% |
| Amicogen, Inc.KOSDAQ: A092040 | $48.83M | ₩924.00 | -6.29% |
| Optipharm.CO.,LTDKOSDAQ: A153710 | $48.80M | ₩4,435.00 | -1.22% |
| GENINUS Inc.KOSDAQ: A389030 | $48.75M | ₩1,650.00 | -15.38% |
Figures last refreshed Oct 18, 2026.